Zantac Lawsuit


Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist

Monday, September 06, 2010

Another fine job by Shelley Jofre - A Risk Worth Taking?

Having just finished watching Shelley Jofre's exposé on GlaxoSmithKline's diabetes drug, Avandia, I am left in no doubt that Glaxo are a huge cock protected by a giant rubber, the rubber being worldwide medicine regulators. This is the only analogy I can come up with at present.

Image: Google Images


No spokesperson from the MHRA or EMA bothered to make any sort of comment. However, earlier today, The Guardian reported that the MHRA had said it had not passed on the recommendation to withdraw Avandia because it would create confusion, and was awaiting a decision by the EMA.

Doncha just love those limp-wristed chappies.

My only surprise is that MHRA officials can sit down, they must have so many splinters pierced into their backsides from all that fence sitting!

Meantime, GSK, Avandia's manufacturer, have urged patients not to panic over the Panorama programme.

Don't panic? I've just watched a half hour documentary that has highlighted how a drug being prescribed by the NHS can cause heart attacks!

Maybe they should have contested the Avandia lawsuits rather than make settlements in the US. Seems to me that it was they who were panicking. $460 million worth of panic to be exact.

This one goes out to the MHRA




A Risk Worth Taking will be available soon on BBC's IPlayer for those of you that missed it. [People outside of the UK may not be able to view IPlayer.]

Big thanks to Shelley Jofre for once again telling it like it is.


Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

No comments:


Please contact me if you would like a guest post considered for publication on my blog.